BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo J, Yang Y, Zhang J, Guo M, Xiang L, Yu S, Ping H, Zhuo L. microRNA‐448 inhibits stemness maintenance and self‐renewal of hepatocellular carcinoma stem cells through the MAGEA6‐mediated AMPK signaling pathway. J Cell Physiol 2019;234:23461-74. [DOI: 10.1002/jcp.28915] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Zhang J, Peng H, Jiang X, Liu Z, Tian H, Hou S, Xie X, Peng Q, Zhou T. Knockdown of miR-92a suppresses the stemness of colorectal cancer cells via mediating SOCS3. Bioengineered 2022;13:5613-24. [DOI: 10.1080/21655979.2021.2022267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Voelz C, Ebrahimy N, Zhao W, Habib P, Zendedel A, Pufe T, Beyer C, Slowik A. Transient Focal Cerebral Ischemia Leads to miRNA Alterations in Different Brain Regions, Blood Serum, Liver, and Spleen. Int J Mol Sci 2021;23:161. [PMID: 35008586 DOI: 10.3390/ijms23010161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen ZQ, Yuan T, Jiang H, Yang YY, Wang L, Fu RM, Luo SQ, Zhang T, Wu ZY, Wen KM. MicroRNA‑8063 targets heterogeneous nuclear ribonucleoprotein AB to inhibit the self‑renewal of colorectal cancer stem cells via the Wnt/β‑catenin pathway. Oncol Rep 2021;46:219. [PMID: 34396427 DOI: 10.3892/or.2021.8170] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Oliveira BSA, de Assis ACC, Souza NM, Ferreira LFR, Soriano RN, Bilal M, Iqbal HMN. Nanotherapeutic approach to tackle chemotherapeutic resistance of cancer stem cells. Life Sci 2021;279:119667. [PMID: 34087280 DOI: 10.1016/j.lfs.2021.119667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wang QF, Wang QL, Cao MB. LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis. Front Med (Lausanne) 2021;8:668787. [PMID: 34055841 DOI: 10.3389/fmed.2021.668787] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Guo JC, Liu Z, Yang YJ, Guo M, Zhang JQ, Zheng JF. KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3/ITGA6 axis. J Cell Mol Med 2021. [PMID: 33829656 DOI: 10.1111/jcmm.16342] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Tomei S, Ibnaof O, Ravindran S, Ferrone S, Maccalli C. Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs. Cancers (Basel) 2021;13:1674. [PMID: 33918136 DOI: 10.3390/cancers13071674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li L, Zhao D, Cheng G, Li Q, Chu Y, Chu H, Ding Y, Li C. β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis. Biosci Rep 2020;40:BSR20194389. [PMID: 32463461 DOI: 10.1042/BSR20194389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Li J, Zhang Y, Ruan R, He W, Qian Y. The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression. Cell Death Dis 2020;11:961. [PMID: 33168816 DOI: 10.1038/s41419-020-03158-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Florke Gee RR, Chen H, Lee AK, Daly CA, Wilander BA, Fon Tacer K, Potts PR. Emerging roles of the MAGE protein family in stress response pathways. J Biol Chem 2020;295:16121-55. [PMID: 32921631 DOI: 10.1074/jbc.REV120.008029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
11 Pu Y, Xiang J, Zhang J. KDM5B-mediated microRNA-448 up-regulation restrains papillary thyroid cancer cell progression and slows down tumor growth via TGIF1 repression. Life Sci 2020;250:117519. [PMID: 32147429 DOI: 10.1016/j.lfs.2020.117519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jiao X, Qian X, Wu L, Li B, Wang Y, Kong X, Xiong L. microRNA: The Impact on Cancer Stemness and Therapeutic Resistance. Cells 2019;9:E8. [PMID: 31861404 DOI: 10.3390/cells9010008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
13 Wang X, Wang X, Li W, Zhang Q, Chen J, Chen T. Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma. Front Oncol 2019;9:1105. [PMID: 31750237 DOI: 10.3389/fonc.2019.01105] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
14 Simbulan-Rosenthal CM, Dougherty R, Vakili S, Ferraro AM, Kuo LW, Alobaidi R, Aljehane L, Gaur A, Sykora P, Glasgow E, Agarwal S, Rosenthal DS. CRISPR-Cas9 Knockdown and Induced Expression of CD133 Reveal Essential Roles in Melanoma Invasion and Metastasis. Cancers (Basel) 2019;11:E1490. [PMID: 31623313 DOI: 10.3390/cancers11101490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]